These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16888393)

  • 1. Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients.
    Wendt-Nordahl G; Rotert H; Trojan L; Michel MS; Peters CR; Alken P; Knoll T
    Med Princ Pract; 2006; 15(5):358-61. PubMed ID: 16888393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of iobitridol in general and in patients with risk factors: results in more than 160,000 patients.
    Maurer M; Heine O; Wolf M; Freyhardt P; Schnapauff D; Hamm B
    Eur J Radiol; 2011 Nov; 80(2):357-62. PubMed ID: 20395094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
    Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
    Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of iobitridol in the general population and at-risk patients.
    Vogl TJ; Honold E; Wolf M; Mohajeri H; Hammerstingl R
    Eur Radiol; 2006 Jun; 16(6):1288-97. PubMed ID: 16429272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of contrast media on renal function in children: comparison of ionic and non-ionic agents.
    Buyan N; Arab M; Hasanoğlu E; Gökçora N; Ercan S
    Turk J Pediatr; 1995; 37(4):305-13. PubMed ID: 8560597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of iopamidol (Iopamiron 370) in intravenous urography in the patients with previous adverse reactions to contrast media and history of allergy].
    Kondo K; Kamidono S; Hamami G
    Hinyokika Kiyo; 1988 Oct; 34(10):1845-51. PubMed ID: 3245531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital.
    Mortelé KJ; Oliva MR; Ondategui S; Ros PR; Silverman SG
    AJR Am J Roentgenol; 2005 Jan; 184(1):31-4. PubMed ID: 15615946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute side effects of iopromide and diatrizoate in urography.
    Sahin H; Bircan MK; Akay AF; Kuru AF
    Acta Radiol; 1998 Nov; 39(6):734-5. PubMed ID: 9817053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical tolerance and diagnostic efficacy of iobitridol in contrast-enhanced CT in children.
    Smets A; Shaw D
    Acta Radiol Suppl; 1996; 400():65-7. PubMed ID: 8619355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance.
    Voth M; Rosenberg M; Breuer J
    Invest Radiol; 2011 Nov; 46(11):663-71. PubMed ID: 21623211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical safety and efficacy of iobitridol in urography.
    Meiss L; Bakker AJ; Falke TH; Van Waes PF
    Acta Radiol Suppl; 1996; 400():68-71. PubMed ID: 8619356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity reactions and contrast medium injection: are they always related?
    Böhm I; Alfke H; Klose KJ
    Eur J Radiol; 2011 Nov; 80(2):368-72. PubMed ID: 21251786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety Analysis of Iobitridol as a Nonionic Contrast Medium: A Postmarketing Multicenter Surveillance Study With 94,960 Patients Almost 20 Years After Introduction.
    Gorodetski B; Heine O; Wolf M; Collettini F; Hamm B; Darmon-Kern E; Penzkofer T
    Invest Radiol; 2020 Mar; 55(3):144-152. PubMed ID: 31977601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse reactions to low osmolar iodine contrast media (second report)].
    Kuwatsuru R; Katayama H; Tomita T; Naoi Y; Hirano A; Miyauchi T; Takeuchi N; Ozaki Y; Nakanishi A; Sumie H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Sep; 52(9):1233-46. PubMed ID: 1437529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late adverse reactions of non-ionic intravenous contrast media].
    Nambu T; Yoshikawa H; Shirato H; Suzuki K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Aug; 50(8):1019-21. PubMed ID: 2235336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multicenter analysis of tolerance and clinical safety of the extracellular MR contrast agent gadobenate dimeglumine (MultiHance)].
    Herborn CU; Jäger-Booth I; Lodemann KP; Spinazzi A; Goyen M
    Rofo; 2009 Jul; 181(7):652-7. PubMed ID: 19291607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and late adverse reactions to low-osmolal contrast media.
    Mikkonen R; Kontkanen T; Kivisaari L
    Acta Radiol; 1995 Jan; 36(1):72-6. PubMed ID: 7833173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography.
    Munechika H; Hiramatsu Y; Kudo S; Sugimura K; Hamada C; Yamaguchi K; Katayama H
    Eur Radiol; 2003 Jan; 13(1):185-94. PubMed ID: 12541129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.